Form 4: Kiromic Biopharma CFO Increases Stake in Company

Brian Hungerford, CFO of Kiromic Biopharma, recently acquired additional shares of the company's common stock through open market purchases.

Summary

• On August 19, 2024, Brian Hungerford, the Chief Financial Officer of Kiromic Biopharma, acquired 258 shares of common stock at a price of $2.25 per share.
• Following this transaction, Mr. Hungerford directly owned 61,191 shares.
• On August 20, 2024, Mr. Hungerford acquired an additional 3,742 shares at $2.197 per share, bringing his total direct ownership to 64,933 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's stock purchase could indicate confidence, but it's a relatively small transaction.

Positives

• The CFO's purchase of additional shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The stock purchases may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Kiromic Biopharma, KRBP, Brian Hungerford, CFO, stock purchase, Form 4, beneficial ownership